Figure 4From: Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy Mean serum concentration-time profiles for C.E.R.A. after subcutaneous injection once every 3 week s.C.E.R.A.: Continuous Erythropoietin Receptor Activator.Q3W: once every three weeks.Back to article page